Wynnefield Capital Inc Catalent, Inc. Transaction History

Wynnefield Capital Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$32.18 - $46.57 $8.05 Million - $11.6 Million	250,000 Added 238.1%	355,000 $16 Million
Q3 2023 Nov 14, 2023	SELL	$44.2 - $50.2 $3.32 Million - $3.77 Million	-75,000 Reduced 41.67%	105,000 $4.78 Million
Q2 2023 Aug 14, 2023	BUY	$31.86 - $67.26 $5.73 Million - $12.1 Million	180,000 New	180,000 $7.8 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Wynnefield Capital Inc, based on Form 13F filings with the SEC.

Stay updated on Wynnefield Capital Inc with notifications on news.